RT Journal Article
SR Electronic
T1 The evolving role of hormone therapy in advanced prostate cancer
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 720
OP 726
VO 67
IS 10
A2 Markman, Maurie
A1 Dreicer, Robert
YR 2000
UL http://www.ccjm.org/content/67/10/720.abstract
AB Earlier diagnosis and treatment of prostate cancer has changed the face of late-stage disease, and the use of mainstay hormonal therapies—orchiectomy, luteinizing hormone releasing-hormone analogs, and combined androgen ablation—are evolving rapidly. New approaches such as antiandrogen monotherapy and intermittent therapy are being evaluated. In addition, palliative treatments for patients with androgen-independent tumors have expanded.